Wellbiotec Co. Ltd. (010600) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) has a cash flow conversion efficiency ratio of -0.033x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-656.53 Million ≈ $-444.92K USD) by net assets (₩20.18 Billion ≈ $13.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wellbiotec Co. Ltd. - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Wellbiotec Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 010600 total liabilities for a breakdown of total debt and financial obligations.
Wellbiotec Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellbiotec Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bio-Works Technologies AB
ST:BIOWKS
|
-0.236x |
|
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
|
-0.004x |
|
Jentayu Sustainables Bhd
KLSE:5673
|
-0.071x |
|
Mohenz.Co.Ltd
KQ:006920
|
0.017x |
|
Camino Minerals Corporation
V:COR
|
-0.025x |
|
TransAct Technologies Incorporated
NASDAQ:TACT
|
0.114x |
|
Wintec Co. Ltd
KQ:320000
|
-0.043x |
|
Serco Group
LSE:SRP
|
0.215x |
Annual Cash Flow Conversion Efficiency for Wellbiotec Co. Ltd. (2005–2024)
The table below shows the annual cash flow conversion efficiency of Wellbiotec Co. Ltd. from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Wellbiotec Co. Ltd. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩20.18 Billion ≈ $13.68 Million |
₩-6.08 Billion ≈ $-4.12 Million |
-0.301x | -168.83% |
| 2023-12-31 | ₩37.22 Billion ≈ $25.22 Million |
₩-4.17 Billion ≈ $-2.82 Million |
-0.112x | -261.35% |
| 2022-12-31 | ₩37.80 Billion ≈ $25.61 Million |
₩2.62 Billion ≈ $1.78 Million |
0.069x | +224.24% |
| 2021-12-31 | ₩33.31 Billion ≈ $22.57 Million |
₩712.97 Million ≈ $483.17K |
0.021x | +107.31% |
| 2020-12-31 | ₩19.49 Billion ≈ $13.21 Million |
₩-5.70 Billion ≈ $-3.87 Million |
-0.293x | -186.49% |
| 2019-12-31 | ₩75.64 Billion ≈ $51.26 Million |
₩-7.73 Billion ≈ $-5.24 Million |
-0.102x | +15.84% |
| 2018-12-31 | ₩76.40 Billion ≈ $51.78 Million |
₩-9.27 Billion ≈ $-6.29 Million |
-0.121x | +18.88% |
| 2017-12-31 | ₩26.85 Billion ≈ $18.20 Million |
₩-4.02 Billion ≈ $-2.72 Million |
-0.150x | -114.19% |
| 2016-12-31 | ₩33.86 Billion ≈ $22.95 Million |
₩-2.37 Billion ≈ $-1.60 Million |
-0.070x | -159.74% |
| 2015-12-31 | ₩36.57 Billion ≈ $24.78 Million |
₩4.28 Billion ≈ $2.90 Million |
0.117x | +367.71% |
| 2014-12-31 | ₩35.12 Billion ≈ $23.80 Million |
₩-1.53 Billion ≈ $-1.04 Million |
-0.044x | -275.96% |
| 2013-12-31 | ₩40.69 Billion ≈ $27.57 Million |
₩1.01 Billion ≈ $684.60K |
0.025x | -70.75% |
| 2012-12-31 | ₩36.04 Billion ≈ $24.42 Million |
₩3.06 Billion ≈ $2.07 Million |
0.085x | +10.03% |
| 2010-12-31 | ₩37.64 Billion ≈ $25.51 Million |
₩2.90 Billion ≈ $1.97 Million |
0.077x | +17.27% |
| 2008-12-31 | ₩47.27 Billion ≈ $32.03 Million |
₩3.11 Billion ≈ $2.11 Million |
0.066x | -39.44% |
| 2006-12-31 | ₩41.38 Billion ≈ $28.04 Million |
₩4.49 Billion ≈ $3.05 Million |
0.109x | +178.98% |
| 2005-12-31 | ₩37.91 Billion ≈ $25.69 Million |
₩1.48 Billion ≈ $1.00 Million |
0.039x | -- |
About Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more